by Krys | Oct 1, 2019 | Clinical Trials, Investigators, Sites
Our marketing department has just released a new brochure with information for medical practitioners interested in adding clinical trials to their practice. The brochure talks about the benefits clinical trials add to your practice, Affinity’s mission and what...
by Krys | Jun 10, 2019 | Clinical Trials, Gastroenterology Trial, Investigators, Research Organisations, Sites, Subject Recruitment
Last Thursday, La Jolla Pharmaceuticals issued a press release stating that the results of the Interim Analysis of the LJ401-HH01 (HERCULES) study confirmed the study had met its primary endpoint. The change in Transferrin Saturation (TSAT) from baseline to the end of...
by Krys | Jun 6, 2019 | Clinical Trials, Investigators, Oncology, Oncology Trial, Subject Safety
Affinity is very excited to start our first patient on genolimzumab, an experimental immunotherapy drug that is one of a group of medicines called Checkpoint Inhibitors. Immunotherapy is a growing therapeutic area for the treatment of cancer both in Australia and...
by Krys | Apr 12, 2019 | Clinical Trials, Investigators, Research Organisations, Sites
Affinity is NOT a one-size-fits-all company. We tailor our services to the individual medical practitioner and to the research project. Research with Affinity does not look the same as the traditional research institution. One example of how Affinity works can be seen...
by Krys | Jun 14, 2018 | Investigators, Sites
Investigator-Initiated research is exciting research. It is attempting to answer questions asked by those at the coal face. Who better than clinicians to know what problems face our patient day-to-day? I have been involved with Investigator-Initiated research for...
by Krys | May 29, 2018 | Clinical Trials, Investigators, Sites
The biggest expense of a research project is people. Hiring qualified, experienced staff is not cheap. It is, however, necessary. Without the right people, it is unlikely the research project will make it out of the starting gates, let alone to the...
